Completed OBSERVATIONAL NCT01705054

Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR)

Sponsor: Gilead Sciences

Conditions Stable Coronary Artery Disease CAD

Updated 8 times since 2017 Last updated: Oct 14, 2021 Started: Jul 31, 2013 Primary completion: Jul 31, 2015 Completion: Jul 22, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Stable Coronary Artery Disease CAD, this trial is completed. The trial is conducted by Gilead Sciences and has accumulated 8 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Nov 2021 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jul 2017 — Apr 2018 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
Jan 2017 — Jul 2017 [monthly]

Enrolling By Invitation NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gilead Sciences
Saint Luke's Health System

Data source: Saint Luke's Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States